Mumbai, June 5 -- The approved product is therapeutically equivalent to the reference listed drug, Haldol Tablets, of Ortho McNeil Pharmaceutical. According to IQVIA data, the product had an estimated market size of approximately $27 million in the United States for the 12 months ended March 2026.

Following the approval, Alembic Pharmaceuticals has a cumulative total of 240 ANDA approvals from the USFDA, comprising 221 final approvals and 19 tentative approvals.

Alembic Pharmaceuticals is a vertically integrated research and development pharmaceutical company. It manufactures and markets generic pharmaceutical products all over the world. Its research and manufacturing facilities are approved by regulatory authorities of many developed ...